Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "There is no dose-response relationship in psychopharmacotherapy" vs "pharmacotherapy in psychiatry is based on ligand-receptor interaction": a unifying hypothesis and the need for plasma concentration based clinical trials.

× No keyword cloud information.

15 in total

1. Therapeutic monitoring of psychotropic drugs: an outline of the AGNP-TDM expert group consensus guideline.

Authors: P Baumann; C Hiemke; S Ulrich; I Gaertner; M L Rao; G Eckermann; M Gerlach; H J Kuss; G Laux; B Müller-Oerlinghausen; P Riederer; G Zernig
Journal: Ther Drug Monit Date: 2004-04 Impact factor: 3.681

2. Serum concentrations of citalopram--dose-dependent variation in R- and S-enantiomer ratios.

Authors: L Tanum; L P Strand; H Refsum
Journal: Pharmacopsychiatry Date: 2010-05-25 Impact factor: 5.788

3. Paroxetine plasma levels: lack of correlation with efficacy or adverse events.

Authors: T C Tasker; C M Kaye; B D Zussman; C G Link
Journal: Acta Psychiatr Scand Suppl Date: 1989

Review 4. Tricyclic antidepressants--blood level measurements and clinical outcome: an APA Task Force report. Task Force on the Use of Laboratory Tests in Psychiatry.

Authors:
Journal: Am J Psychiatry Date: 1985-02 Impact factor: 18.112

5. Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study.

Authors: Gerhard Gründer; Christine Fellows; Hildegard Janouschek; Tanja Veselinovic; Christian Boy; Anno Bröcheler; Katrin M Kirschbaum; Sandra Hellmann; Katja M Spreckelmeyer; Christoph Hiemke; Frank Rösch; Wolfgang M Schaefer; Ingo Vernaleken
Journal: Am J Psychiatry Date: 2008-04-01 Impact factor: 18.112

6. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption.

Authors: Manfred Uhr; Markus T Grauer; Florian Holsboer
Journal: Biol Psychiatry Date: 2003-10-15 Impact factor: 13.382

7. The serotonin syndrome scale: first results on validity.

Authors: U Hegerl; R Bottlender; J Gallinat; H J Kuss; M Ackenheil; H J Möller
Journal: Eur Arch Psychiatry Clin Neurosci Date: 1998 Impact factor: 5.270

8. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression.

Authors: Yutaro Suzuki; Naoki Fukui; Kazushi Sawamura; Takuro Sugai; Junzo Watanabe; Shin Ono; Yoshimasa Inoue; Vural Ozdemir; Toshiyuki Someya
Journal: J Clin Psychopharmacol Date: 2008-06 Impact factor: 3.153

9. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.

Authors: Jeffrey H Meyer; Alan A Wilson; Sandra Sagrati; Doug Hussey; Anna Carella; William Z Potter; Nathalie Ginovart; Edgar P Spencer; Andy Cheok; Sylvain Houle
Journal: Am J Psychiatry Date: 2004-05 Impact factor: 18.112

Review 10. Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review.

Authors: Mazda Adli; Christopher Baethge; Andreas Heinz; Nicolas Langlitz; Michael Bauer
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2005-04-29 Impact factor: 5.760

1 in total

1. The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

Authors: Tetsu Tomita; Norio Yasui-Furukori; Taku Nakagami; Shoko Tsuchimine; Masamichi Ishioka; Ayako Kaneda; Norio Sugawara; Sunao Kaneko
Journal: PLoS One Date: 2014-05-23 Impact factor: 3.240

1 in total